NDC 50090-4490
ENBREL
Etanercept
ENBREL is a Subcutaneous Solution in the Human Prescription Drug category. It is labeled and distributed by A-s Medication Solutions. The primary component is Etanercept.
| Product ID | 50090-4490_6fc34018-1d3c-485d-b5a5-fe31246f75b4 |
| NDC | 50090-4490 |
| Product Type | Human Prescription Drug |
| Proprietary Name | ENBREL |
| Generic Name | Etanercept |
| Dosage Form | Solution |
| Route of Administration | SUBCUTANEOUS |
| Marketing Start Date | 2005-11-10 |
| Marketing Category | BLA / BLA |
| Application Number | BLA103795 |
| Labeler Name | A-S Medication Solutions |
| Substance Name | ETANERCEPT |
| Active Ingredient Strength | 50 mg/mL |
| Pharm Classes | Tumor Necrosis Factor Blocker [EPC],Tumor Necrosis Factor Receptor Blocking Activity [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
Packaging
NDC 50090-4490-0
1 mL in 1 KIT (50090-4490-0)
| Marketing Start Date | 2019-08-29 |
| NDC Exclude Flag | N |
| Sample Package? | N |
NDC SPL Data Element Entries
NDC 50090-4490-0 [50090449000]
ENBREL SOLUTION
| Marketing Category | BLA |
| Application Number | BLA103795 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-08-29 |
Drug Details
Active Ingredients
| Ingredient | Strength |
|---|---|
| ETANERCEPT | 50 mg/mL |
OpenFDA Data
| SPL SET ID: | 2dc2ed4b-f234-4ccc-bd95-0b63ac3ef421 |
| Manufacturer | |
| UNII |
Pharmacological Class
- Tumor Necrosis Factor Blocker [EPC]
- Tumor Necrosis Factor Receptor Blocking Activity [MoA]
- Tumor Necrosis Factor Blocker [EPC]
- Tumor Necrosis Factor Receptor Blocking Activity [MoA]
NDC Crossover Matching brand name "ENBREL" or generic name "Etanercept"
| NDC | Brand Name | Generic Name |
|---|---|---|
| 50090-3531 | ENBREL | etanercept |
| 50090-4490 | ENBREL | etanercept |
| 50090-4590 | ENBREL | etanercept |
| 58406-010 | ENBREL | etanercept |
| 58406-021 | ENBREL | etanercept |
| 58406-032 | ENBREL | etanercept |
| 58406-044 | ENBREL | etanercept |
| 58406-455 | ENBREL | ENBREL |
| 58406-456 | ENBREL | ENBREL |
| 58406-425 | ENBREL | ENBREL |
| 58406-435 | ENBREL | ENBREL |
| 58406-445 | ENBREL | ENBREL |
| 58406-446 | ENBREL | ENBREL |
| 58406-055 | ENBREL | ENBREL |
Trademark Results [ENBREL]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 ENBREL 75603024 not registered Dead/Abandoned |
Immunex Corporation 1998-12-09 |
 ENBREL 75602028 2402704 Dead/Cancelled |
Immunex Corporation 1998-12-09 |
 ENBREL 75602027 not registered Dead/Abandoned |
Immunex Corporation 1998-12-09 |
 ENBREL 75183260 2220795 Live/Registered |
IMMUNEX CORPORATION 1996-10-17 |
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.